Rocket


News + Filings
Transactions





Dhingra Kapil

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/16/2023Black Diamond Therapeutics, Inc.BDTXGrantStock Option (Right to Buy)16.5k$1.82$30k 05/16/2023
04/01/2023Replimune Group, Inc.REPLGrantStock Option (right to buy)25.2k$17.66$445k 04/01/2023
06/10/2022Black Diamond Therapeutics, Inc.BDTXGrantStock Option (Right to Buy)15k$2.14$32.1k 06/10/2022
04/01/2022Replimune Group, Inc.REPLGrantStock Option (right to buy)16.5k$18.26$301.3k 04/01/2022
06/18/2021Black Diamond Therapeutics, Inc.BDTXGrantStock Option (Right to Buy)15k$12.55$188.2k 06/18/2021
04/16/2021FIVE PRIME THERAPEUTICS, INC.FPRXDispositionStock Option (right to buy)20k$4.14$82.8k 04/16/2021
04/16/2021FIVE PRIME THERAPEUTICS, INC.FPRXDispositionStock Option (right to buy)15k$6.09$91.4k 04/16/2021
04/16/2021FIVE PRIME THERAPEUTICS, INC.FPRXDispositionStock Option (right to buy)10k$17.27$172.7k 04/16/2021
04/16/2021FIVE PRIME THERAPEUTICS, INC.FPRXDispositionStock Option (right to buy)10k$29.80$298k 04/16/2021
04/16/2021FIVE PRIME THERAPEUTICS, INC.FPRXDispositionStock Option (right to buy)25k$37.99$949.8k 04/16/2021
04/01/2021Replimune Group, Inc.REPLGrantStock Option (right to buy)16.5k$31.58$521.1k 04/01/2021
01/19/2021Black Diamond Therapeutics, Inc.BDTXGrantStock Option (Right to Buy)29.8k$27.45$819.2k 01/19/2021
12/07/2020Replimune Group, Inc.REPLSaleCommon Stock24.7k$45.09$1.1M 12/07/2020
12/07/2020Replimune Group, Inc.REPLSaleCommon Stock13.5k$46.22$625k 12/07/2020
12/07/2020Replimune Group, Inc.REPLSaleCommon Stock1.8k$47.04$84.8k 12/07/2020
12/07/2020Replimune Group, Inc.REPLExerciseStock Option (right to buy)40k$1.75$70k 12/07/2020
05/14/2020FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)20k$4.14$82.8k 05/14/2020
04/01/2020Replimune Group, Inc.REPLGrantStock Option (right to buy)16.5k$9.78$161.4k 04/01/2020
06/10/2019FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)15k$6.09$91.4k 06/10/2019
04/01/2019Replimune Group, Inc.REPLGrantStock Option (right to buy)13.5k$15.50$209.2k 04/01/2019
07/24/2018Replimune Group, Inc.REPLGrantStock Option (right to buy)13.5k$15.00$202.5k 07/24/2018
05/10/2018FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)10k$17.27$172.7k 05/10/2018
05/10/2017FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)10k$29.80$298k 05/10/2017
05/19/2016FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)10k$42.25$422.5k 05/19/2016

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy